Director, Business Development, AlgometRx Inc.
Dan Gura, PharmD, MPH is Director of Business Development at AlgometRx, Inc., a medical device start-up based in Washington, DC. AlgometRx, Inc. is a platform technology founded by a pediatric anesthesiologist to objectively measure pain in real time, both its type and intensity, as well as determine drug effect to refine interventions used for pain management in both adult and pediatric patient populations. Dan was formerly Director of Business Development at CommGenix , a medical education company, where he oversaw the pain and healthcare technology platforms. Dan served as Associate Scientific Director at the Geriatric Oncology Consortium (GOC), a non-profit agency dedicated to improving care of elderly patients with cancer through clinical research and education. Prior to the GOC, Dan worked at M. D. Anderson Cancer Center, Houston, TX, in the Department of Pain and Symptom Management. His research focused on the natural history of phantom limb/stump pain in pediatric and adult cancer amputees. Dan earned his Bachelor of Arts degree from Swarthmore College, his Master of Public Health degree from the UT Houston Health Science Center, and his Doctor of Pharmacy degree from the University of Texas at Austin College of Pharmacy/UT San Antonio Health Science Center. He received post-doctoral fellowship training in health economics/epidemiology from Yale University College of Medicine, School of Public Health.